🇬🇧 Locametz in United Kingdom

MHRA authorised Locametz on 9 December 2022

Marketing authorisation

MHRA — authorised 9 December 2022

  • Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
  • Status: approved

Locametz in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Locametz approved in United Kingdom?

Yes. MHRA authorised it on 9 December 2022.

Who is the marketing authorisation holder for Locametz in United Kingdom?

NOVARTIS EUROPHARM LIMITED holds the UK marketing authorisation.